|
Reference #:
2004-273
Inventors/Contributors
Richard M. Weinshilboum, M.D., Oreste Ezequiel Salavaggione, M.D., Baidehi (Luna) Mukherjee, Linda L. Pelleymounter, Eric D. Wieben, Ph.D.
Description
GST02 is a phase II enzyme that utilize glutathione in reactions contributing to the transformation of a wide range of exogenous and endogenous compounds, including carcinogens, therapeutic drugs, and products of oxidative stress. Known substrates are glutathione (GSH) and dehydroascorbate (DHA. It is expressed in liver, kidney and skeletal muscle and at high levels in the testes and low levels in the heart, lung, cervix, ovary and prostate. Three novel non-synonymous cSNPs have been identified and their functional relevancy is being determined. Novel polymorphisms and common haplotypes for Caucasian American, African American, Han Chinese and Mexican American populations have been identified.
Patent Status
|
|
Contact
Leif R. Nelson, Licensing Manager
nelson.leif@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 266-0820
Fax: (507) 284-5410
|
|
|